Market Research Report - 233576
Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer
|Published by||BioSeeker Group AB|
|Published||Content info||3635 Pages|
|Triple Analysis: Breast Cancer, Melanoma and Pancreatic Cancer|
|Published: June 12, 2013||Content info: 3635 Pages||
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.